¶ Secondary Hyperalgesia
¶ Definition
Secondary hyperalgesia is pain hypersensitivity occurring in tissue surrounding an injury site or in uninjured tissue remote from the primary lesion, mediated by central sensitization of spinal and supraspinal nociceptive pathways rather than peripheral sensitization. Unlike Primary hyperalgesia which reflects peripheral nociceptor changes at the injury site, secondary hyperalgesia is a pure CNS phenomenon involving expanded receptive fields, reduced inhibition, and amplified responses to normally non-painful stimuli (allodynia). This is a hallmark of maladaptive neuroplasticity and a key predictor of chronic pain development.
¶ Picture It
Imagine a burglar alarm system in a building. Primary hyperalgesia is like having the sensors in one room become oversensitive — they now trigger on smaller vibrations. But secondary hyperalgesia is when the central control panel itself gets reprogrammed. Now sensors in distant rooms that weren't even touched by the burglar start triggering alarms at the slightest movement — a gentle breeze through a window sets off sirens. The wiring hasn't changed in those distant rooms; the problem is in the central processing unit that's now interpreting all signals as threats.
This happens because the alarm company's computer (the dorsal horn) learned from repeated break-ins that threats are everywhere. It lowered all thresholds, expanded its monitoring zone, and started treating normal signals as emergency alerts. Even rooms that have never seen a burglar now behave as if they're high-risk zones. The problem isn't local — it's systemic, centralized, and requires reprogramming the control panel, not fixing individual sensors.
¶ Mechanism
Secondary hyperalgesia is generated entirely within the CNS through activity-dependent plasticity in spinal dorsal horn neurons and supraspinal circuits:
¶ Spinal Level (Dorsal Horn):
Initiating cascade:
- Repeated or intense C-fibre nociceptive input → glutamate release at dorsal horn synapses
- Glutamate binds NMDA receptors (initially blocked by Mg²⁺ at resting potential)
- Depolarization from AMPA receptor activation → Mg²⁺ unblocking of NMDA receptors
- NMDA receptor activation → Ca²⁺ influx → activation of CaMKII, PKC, PKA
- These kinases phosphorylate AMPA receptors → increased channel conductance
- Long-Term Potentiation (LTP) is established at nociceptive synapses
Receptive field expansion:
- Dorsal horn wide-dynamic-range neurons normally have receptive fields ~5-10 cm²
- During central sensitization, silent synapses (from A-beta fibres carrying touch) become active
- PKC phosphorylation of glycine receptors → reduced inhibition
- Lateral spread of excitation across spinal segments
- Receptive fields expand up to 10-fold (50-100 cm²)
- Now mechanical touch activates pain pathways ("tactile allodynia")
Wind-up phenomenon:
- Repeated C-fibre stimulation at >0.5 Hz → temporal summation
- Progressive increase in action potential output from dorsal horn neurons
- Each stimulus produces greater response than previous (despite identical input)
- Mediated by NMDA receptors and Substance P acting on NK1 receptors
- Requires
seconds between stimuli to maintain summation
¶ Descending Modulation:
Facilitation from RVM:
- RVM "ON-cells" (pronociceptive) become hyperactive
- Increased serotonin release onto 5-HT₃ receptors in dorsal horn → facilitation
- Decreased serotonin at 5-HT₁A/₁B receptors → loss of inhibition
- NMDA receptor-dependent plasticity in RVM itself mirrors spinal changes
- Creates "pain memory" at brainstem level
Loss of inhibition:
- PAG and RVM "OFF-cells" (antinociceptive) reduce firing
- Reduced Noradrenaline and serotonin at α₂-adrenergic receptors in dorsal horn
- Endogenous opioid system becomes less effective (Endorphin resistance)
- GABAergic and glycinergic interneurons downregulate → disinhibition
¶ Supraspinal Contributions:
- ACC and Anterior insula show increased activation to innocuous stimuli in secondary hyperalgesia zones
- Prefrontal cortex shows reduced Top-Down Control over pain processing
- Amygdala becomes hyperresponsive → emotional amplification of pain signals
- Forms basis of Neurologic Pain Signature (NPS)
¶ Clinical Significance
¶ Diagnostic Marker:
Secondary hyperalgesia is a clinical gold standard for identifying central sensitization. When a patient reports pain spreading beyond the injury site or develops tactile allodynia in uninjured tissue, the nervous system has shifted from nociception to pathological amplification.
Testing protocol:
- Von Frey filament testing in zones >5 cm from injury
- Threshold typically drops from 26g (normal) to <4g in secondary zones
- Pinprick testing shows hyperalgesia where tissue is undamaged
- Brush-evoked pain (dynamic mechanical allodynia) indicates A-beta fibres now access pain pathways
¶ Chronification Risk:
Presence of secondary hyperalgesia predicts transition to chronic pain:
- In acute low back pain, secondary hyperalgesia at baseline → 4x risk of pain at 6 months
- Post-surgical patients with secondary hyperalgesia zones >10 cm² → 3x risk of chronic post-surgical pain
- Secondary hyperalgesia expanding over first 48 hours post-injury indicates maladaptive neuroplasticity in progress
¶ Metamodel 5 Plus 2 Relevance:
Secondary hyperalgesia exemplifies failure of the nervous system's "energy governor":
- Selfish Brain attempting to reduce movement/activity in distant body regions to conserve energy for healing
- Overshoot of protective mechanism becomes maladaptive
- Related to Early Life Stress (ELS) → individuals with Adverse childhood experiences show lower thresholds for developing secondary hyperalgesia (primed Dorsal horn circuitry)
- Maternal Separation (MS) in animal models creates lifelong vulnerability to secondary hyperalgesia via HPA-axis and Glucocorticoid Receptor alterations
¶ Intervention Implications:
Must target CNS, not periphery:
- Local injections/treatments in secondary zones are futile (tissue is normal)
- NMDA antagonists (e.g., ketamine 0.1-0.5 mg/kg) can reverse established secondary hyperalgesia
- Descending modulation enhancement: Exercise, Meditation, CBT, vagal nerve stimulation
- Pain neuroscience education to reduce threat interpretation → reduces ACC hyperactivity
- Conditioned Pain Modulation training (e.g., cold pressor test) to reactivate endogenous inhibition
Nutritional support:
- Omega-3 fatty acids (EPA 2g/day) → reduce NMDA receptor phosphorylation via modulation of PKC
- Magnesium (400-600 mg/day) → NMDA receptor antagonism at physiological Mg²⁺ block site
- Curcumin (1g/day) → inhibits NF-κB and reduces dorsal horn Microglia activation that maintains central sensitization
¶ Connection to Other Pain Syndromes:
- Fibromyalgia shows whole-body secondary hyperalgesia (generalized central sensitization)
- Visceral Hypersensitivity in IBS involves identical mechanisms in spinal visceral afferent processing
- Migraine involves secondary hyperalgesia of cranial structures (cutaneous allodynia during attacks)
- Complex regional pain syndrome shows progressive secondary hyperalgesia expansion as hallmark feature
¶ Key Facts
- Secondary hyperalgesia occurs in tissue >5 cm from injury site where there is no tissue damage or peripheral sensitization
- Mediated entirely by CNS plasticity, not peripheral nociceptor changes
- NMDA receptor activation is necessary and sufficient to induce secondary hyperalgesia in animal models
- Von Frey thresholds drop from normal 26g to <4g in secondary zones
- Receptive field expansion of dorsal horn neurons can reach 10-fold increase (5 cm² → 50 cm²)
- Wind-up requires stimulation frequency >0.5 Hz and inter-stimulus intervals seconds
- Develops within minutes to hours after intense/repeated nociceptive input (much faster than chronic pain)
- RVM ON-cells show increased spontaneous activity 50-200% in chronic secondary hyperalgesia
- Secondary hyperalgesia zones >10 cm² at 48 hours post-injury predict chronic pain with OR = 3.2
- Presence of dynamic mechanical allodynia (brush-evoked pain) indicates A-beta fibres now activate Lamina I nociceptive projection neurons via phenotypic switch
- Ketamine at subanesthetic doses (0.1-0.5 mg/kg) can reverse established secondary hyperalgesia within 30-60 minutes
- Early Life Stress (ELS) lowers threshold for secondary hyperalgesia development by 30-40% in adult life via persistent HPA-axis priming
¶ Connections
- Primary hyperalgesia — contrasts with this peripheral phenomenon occurring at injury site itself
- Central sensitization — underlying mechanism; secondary hyperalgesia is the clinical manifestation
- Peripheral sensitization — ruled out by definition in secondary hyperalgesia zones
- Dorsal horn — anatomical site where receptive field expansion and LTP occur
- NMDA receptor — critical receptor mediating wind-up and LTP establishment
- Long-Term Potentiation (LTP) — synaptic plasticity mechanism underlying secondary hyperalgesia maintenance
- Allodynia — pain from normally non-painful stimuli; hallmark clinical finding in secondary zones
- A-beta fibres — normally non-nociceptive mechanoreceptors that gain access to pain pathways during central sensitization
- RVM — source of descending facilitation that maintains secondary hyperalgesia
- PAG — reduced descending inhibition contributes to maintenance phase
- Chronic pain syndromes — secondary hyperalgesia predicts transition to chronicity
- Fibromyalgia — extreme example with whole-body secondary hyperalgesia
- Visceral Hypersensitivity — visceral equivalent using same dorsal horn mechanisms
- Neuroplasticity — maladaptive form leading to pain amplification
- Substance P — neurokinin-1 receptor activation contributes to wind-up phenomenon
- Early Life Stress (ELS) — creates vulnerability to excessive secondary hyperalgesia development
- ACC — shows hyperactivation to innocuous stimuli in secondary zones
- Anterior insula — interoceptive processing amplifies pain signals in secondary hyperalgesia
- Conditioned Pain Modulation — assessment tool and therapeutic target for secondary hyperalgesia
- Pain neuroscience education — reduces threat value and can shrink secondary hyperalgesia zones
- Omega-3 — modulates NMDA receptor function and reduces secondary hyperalgesia in clinical trials
- Magnesium — physiological NMDA receptor antagonist useful in prevention
- Curcumin — reduces dorsal horn neuroinflammation supporting central sensitization
- Ketamine — NMDA antagonist capable of reversing established secondary hyperalgesia
- Exercise — enhances descending inhibition and reduces secondary hyperalgesia zones
- Neurologic Pain Signature (NPS) — brain-based biomarker incorporating secondary hyperalgesia processing
¶ Module References
- Module 5